INJURY 润色咨询

INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED

出版年份:1969 年文章数:8378 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:23.9% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=574122, encodeId=d3175e41224d, content=现在呢<span class="quote">zhouxindie 2019-04-12 00:00:00 发表:<br>with editor快3个月了,催了两次,说还没送审</span>, beContent=zhouxindie 2019-04-12 00:00:00 发表: with editor快3个月了,催了两次,说还没送审, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sun Jul 28 00:00:00 CST 2019, time=2019-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090422, encodeId=c37b209042230, content=我觉得这个杂志还是比较友好的,审稿不是很慢,大概一个月左右。大修一个月的时间,修回后大概1月后催了一次就直接接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=372f4741510, createdName=liangfang1024, createdTime=Mon Sep 26 10:18:02 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235190, encodeId=31b61235190c7, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:创伤<br>经验分享:本人投稿接近投了9个月,最后终于接收了,感觉这杂志的编辑还是很友好的,催了好多次,每次回复都很耐心且态度较好,不过审稿过程较慢,投这个杂志的一定要耐心,如果着急的话不建议投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erd3qzSYf75jcv9Odg4KVtGhseFWgqWtUmlzIs07zwVc5Zk9uHbp49tlsY7dDGI8df08N1cUO2utQ/132, createdBy=df882569019, createdName=kkun, createdTime=Wed Jul 27 23:08:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227282, encodeId=0917122e28267, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:Biomechanics;Femoral neck Fractures;骨科<br>经验分享:2022-02-09投稿,2022-03under review,2022-05-23 review结束。紧张等待半个月后,2022-06-09直接接收。虽然送审时间长了点,under review基本固定在两个月左右,但总体而言比第一次更顺利些。审稿专家也很专业、客观。第一次外审后直接接收,得到专家肯定总会令人开心😃。从投稿到接收刚刚历时4个月,速度中规中矩,但是见刊速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/bd3f667e39e457213af659d09c7c2388.jpg, createdBy=e4752544775, createdName=请输入昵称, createdTime=Sat Jun 18 22:41:09 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945114, encodeId=14e49451148f, content=审稿速度:6.0 | 投稿命中率:95.0<br>经验分享:2020-10-24投稿<br>2021-02-27审回,minor revision, editor see again<br>2021-3-1修回,2天后accept<br>一篇研究IRI的基础文章,第一个审稿人未提出修改意见,第二个审稿人说不适合本杂志,第三个审稿人针对讨论提出了点小意见。对骨科研究还是很友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/943A474B8B87FD1E832DF0998921350E/100, createdBy=48852061131, createdName=shushu158, createdTime=Wed Mar 03 13:57:21 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186337, encodeId=61cf118633e51, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:脊柱创伤<br>经验分享:差评。审稿十个月,一个说观点新颖,一个说没有使用价值,我觉得这个杂志不好,审稿慢,态度不好,催稿1次,不宜接受新东西, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4061585713, createdName=duzi83410, createdTime=Thu Jan 20 09:17:50 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078121, encodeId=fb1110e812159, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:创伤骨科<br>经验分享:投稿9个月,两个意见,一个worthy of publication,一个建议大修。最后直接给拒了<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57062061668, createdName=1521ee135cm, createdTime=Wed Dec 08 16:04:47 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469975, encodeId=1dd24699e529, content=大概审稿周期:需要三个月 <br> 出版周期:目前还不清楚 <br> 是否需要审稿费和版面费:不需要 <br> 个人感觉难度:感觉难度一般,语言要求不高 <br> 是否有在线投稿系统:有 <br> 是否免费开放获取全文(open access):非 <br> 个人感觉:这个杂志虽然是骨科老牌杂志,但是个人感觉对稿件的要求较BONE和SPINE低很多,我们实验室投了两篇都已经接受发表,一个直接接受,另外一个是minor revision,所以投bone失败的战友不妨一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=浮云游子, createdTime=Tue Dec 29 08:59:00 CST 2009, time=2009-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861929, encodeId=0cb5861929ea, content=02.20投稿,2个月后小修,6天后返修回去,05.02接收,05.22 online。感觉编辑较为看中论文的创新性,临床研究的质量尚在其次。修回意见很专业,投稿流程很人性化。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Mon Jun 15 12:42:43 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578553, encodeId=939e5e855348, content=命中率高不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]
    2019-07-28 12415e1cm11暂无昵称

    现在呢zhouxindie 2019-04-12 00:00:00 发表:
    with editor快3个月了,催了两次,说还没送审

    zhouxindie 2019-04-12 00:00:00 发表: with editor快3个月了,催了两次,说还没送审

    4

    展开4条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=574122, encodeId=d3175e41224d, content=现在呢<span class="quote">zhouxindie 2019-04-12 00:00:00 发表:<br>with editor快3个月了,催了两次,说还没送审</span>, beContent=zhouxindie 2019-04-12 00:00:00 发表: with editor快3个月了,催了两次,说还没送审, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sun Jul 28 00:00:00 CST 2019, time=2019-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090422, encodeId=c37b209042230, content=我觉得这个杂志还是比较友好的,审稿不是很慢,大概一个月左右。大修一个月的时间,修回后大概1月后催了一次就直接接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=372f4741510, createdName=liangfang1024, createdTime=Mon Sep 26 10:18:02 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235190, encodeId=31b61235190c7, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:创伤<br>经验分享:本人投稿接近投了9个月,最后终于接收了,感觉这杂志的编辑还是很友好的,催了好多次,每次回复都很耐心且态度较好,不过审稿过程较慢,投这个杂志的一定要耐心,如果着急的话不建议投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erd3qzSYf75jcv9Odg4KVtGhseFWgqWtUmlzIs07zwVc5Zk9uHbp49tlsY7dDGI8df08N1cUO2utQ/132, createdBy=df882569019, createdName=kkun, createdTime=Wed Jul 27 23:08:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227282, encodeId=0917122e28267, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:Biomechanics;Femoral neck Fractures;骨科<br>经验分享:2022-02-09投稿,2022-03under review,2022-05-23 review结束。紧张等待半个月后,2022-06-09直接接收。虽然送审时间长了点,under review基本固定在两个月左右,但总体而言比第一次更顺利些。审稿专家也很专业、客观。第一次外审后直接接收,得到专家肯定总会令人开心😃。从投稿到接收刚刚历时4个月,速度中规中矩,但是见刊速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/bd3f667e39e457213af659d09c7c2388.jpg, createdBy=e4752544775, createdName=请输入昵称, createdTime=Sat Jun 18 22:41:09 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945114, encodeId=14e49451148f, content=审稿速度:6.0 | 投稿命中率:95.0<br>经验分享:2020-10-24投稿<br>2021-02-27审回,minor revision, editor see again<br>2021-3-1修回,2天后accept<br>一篇研究IRI的基础文章,第一个审稿人未提出修改意见,第二个审稿人说不适合本杂志,第三个审稿人针对讨论提出了点小意见。对骨科研究还是很友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/943A474B8B87FD1E832DF0998921350E/100, createdBy=48852061131, createdName=shushu158, createdTime=Wed Mar 03 13:57:21 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186337, encodeId=61cf118633e51, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:脊柱创伤<br>经验分享:差评。审稿十个月,一个说观点新颖,一个说没有使用价值,我觉得这个杂志不好,审稿慢,态度不好,催稿1次,不宜接受新东西, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4061585713, createdName=duzi83410, createdTime=Thu Jan 20 09:17:50 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078121, encodeId=fb1110e812159, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:创伤骨科<br>经验分享:投稿9个月,两个意见,一个worthy of publication,一个建议大修。最后直接给拒了<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57062061668, createdName=1521ee135cm, createdTime=Wed Dec 08 16:04:47 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469975, encodeId=1dd24699e529, content=大概审稿周期:需要三个月 <br> 出版周期:目前还不清楚 <br> 是否需要审稿费和版面费:不需要 <br> 个人感觉难度:感觉难度一般,语言要求不高 <br> 是否有在线投稿系统:有 <br> 是否免费开放获取全文(open access):非 <br> 个人感觉:这个杂志虽然是骨科老牌杂志,但是个人感觉对稿件的要求较BONE和SPINE低很多,我们实验室投了两篇都已经接受发表,一个直接接受,另外一个是minor revision,所以投bone失败的战友不妨一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=浮云游子, createdTime=Tue Dec 29 08:59:00 CST 2009, time=2009-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861929, encodeId=0cb5861929ea, content=02.20投稿,2个月后小修,6天后返修回去,05.02接收,05.22 online。感觉编辑较为看中论文的创新性,临床研究的质量尚在其次。修回意见很专业,投稿流程很人性化。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Mon Jun 15 12:42:43 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578553, encodeId=939e5e855348, content=命中率高不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]
    2022-09-26 liangfang1024

    我觉得这个杂志还是比较友好的,审稿不是很慢,大概一个月左右。大修一个月的时间,修回后大概1月后催了一次就直接接收了。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=574122, encodeId=d3175e41224d, content=现在呢<span class="quote">zhouxindie 2019-04-12 00:00:00 发表:<br>with editor快3个月了,催了两次,说还没送审</span>, beContent=zhouxindie 2019-04-12 00:00:00 发表: with editor快3个月了,催了两次,说还没送审, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sun Jul 28 00:00:00 CST 2019, time=2019-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090422, encodeId=c37b209042230, content=我觉得这个杂志还是比较友好的,审稿不是很慢,大概一个月左右。大修一个月的时间,修回后大概1月后催了一次就直接接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=372f4741510, createdName=liangfang1024, createdTime=Mon Sep 26 10:18:02 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235190, encodeId=31b61235190c7, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:创伤<br>经验分享:本人投稿接近投了9个月,最后终于接收了,感觉这杂志的编辑还是很友好的,催了好多次,每次回复都很耐心且态度较好,不过审稿过程较慢,投这个杂志的一定要耐心,如果着急的话不建议投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erd3qzSYf75jcv9Odg4KVtGhseFWgqWtUmlzIs07zwVc5Zk9uHbp49tlsY7dDGI8df08N1cUO2utQ/132, createdBy=df882569019, createdName=kkun, createdTime=Wed Jul 27 23:08:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227282, encodeId=0917122e28267, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:Biomechanics;Femoral neck Fractures;骨科<br>经验分享:2022-02-09投稿,2022-03under review,2022-05-23 review结束。紧张等待半个月后,2022-06-09直接接收。虽然送审时间长了点,under review基本固定在两个月左右,但总体而言比第一次更顺利些。审稿专家也很专业、客观。第一次外审后直接接收,得到专家肯定总会令人开心😃。从投稿到接收刚刚历时4个月,速度中规中矩,但是见刊速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/bd3f667e39e457213af659d09c7c2388.jpg, createdBy=e4752544775, createdName=请输入昵称, createdTime=Sat Jun 18 22:41:09 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945114, encodeId=14e49451148f, content=审稿速度:6.0 | 投稿命中率:95.0<br>经验分享:2020-10-24投稿<br>2021-02-27审回,minor revision, editor see again<br>2021-3-1修回,2天后accept<br>一篇研究IRI的基础文章,第一个审稿人未提出修改意见,第二个审稿人说不适合本杂志,第三个审稿人针对讨论提出了点小意见。对骨科研究还是很友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/943A474B8B87FD1E832DF0998921350E/100, createdBy=48852061131, createdName=shushu158, createdTime=Wed Mar 03 13:57:21 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186337, encodeId=61cf118633e51, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:脊柱创伤<br>经验分享:差评。审稿十个月,一个说观点新颖,一个说没有使用价值,我觉得这个杂志不好,审稿慢,态度不好,催稿1次,不宜接受新东西, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4061585713, createdName=duzi83410, createdTime=Thu Jan 20 09:17:50 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078121, encodeId=fb1110e812159, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:创伤骨科<br>经验分享:投稿9个月,两个意见,一个worthy of publication,一个建议大修。最后直接给拒了<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57062061668, createdName=1521ee135cm, createdTime=Wed Dec 08 16:04:47 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469975, encodeId=1dd24699e529, content=大概审稿周期:需要三个月 <br> 出版周期:目前还不清楚 <br> 是否需要审稿费和版面费:不需要 <br> 个人感觉难度:感觉难度一般,语言要求不高 <br> 是否有在线投稿系统:有 <br> 是否免费开放获取全文(open access):非 <br> 个人感觉:这个杂志虽然是骨科老牌杂志,但是个人感觉对稿件的要求较BONE和SPINE低很多,我们实验室投了两篇都已经接受发表,一个直接接受,另外一个是minor revision,所以投bone失败的战友不妨一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=浮云游子, createdTime=Tue Dec 29 08:59:00 CST 2009, time=2009-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861929, encodeId=0cb5861929ea, content=02.20投稿,2个月后小修,6天后返修回去,05.02接收,05.22 online。感觉编辑较为看中论文的创新性,临床研究的质量尚在其次。修回意见很专业,投稿流程很人性化。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Mon Jun 15 12:42:43 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578553, encodeId=939e5e855348, content=命中率高不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]
    2022-07-27 kkun

    审稿速度:12.0 | 投稿命中率:50.0
    偏重的研究方向:创伤
    经验分享:本人投稿接近投了9个月,最后终于接收了,感觉这杂志的编辑还是很友好的,催了好多次,每次回复都很耐心且态度较好,不过审稿过程较慢,投这个杂志的一定要耐心,如果着急的话不建议投

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=574122, encodeId=d3175e41224d, content=现在呢<span class="quote">zhouxindie 2019-04-12 00:00:00 发表:<br>with editor快3个月了,催了两次,说还没送审</span>, beContent=zhouxindie 2019-04-12 00:00:00 发表: with editor快3个月了,催了两次,说还没送审, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sun Jul 28 00:00:00 CST 2019, time=2019-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090422, encodeId=c37b209042230, content=我觉得这个杂志还是比较友好的,审稿不是很慢,大概一个月左右。大修一个月的时间,修回后大概1月后催了一次就直接接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=372f4741510, createdName=liangfang1024, createdTime=Mon Sep 26 10:18:02 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235190, encodeId=31b61235190c7, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:创伤<br>经验分享:本人投稿接近投了9个月,最后终于接收了,感觉这杂志的编辑还是很友好的,催了好多次,每次回复都很耐心且态度较好,不过审稿过程较慢,投这个杂志的一定要耐心,如果着急的话不建议投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erd3qzSYf75jcv9Odg4KVtGhseFWgqWtUmlzIs07zwVc5Zk9uHbp49tlsY7dDGI8df08N1cUO2utQ/132, createdBy=df882569019, createdName=kkun, createdTime=Wed Jul 27 23:08:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227282, encodeId=0917122e28267, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:Biomechanics;Femoral neck Fractures;骨科<br>经验分享:2022-02-09投稿,2022-03under review,2022-05-23 review结束。紧张等待半个月后,2022-06-09直接接收。虽然送审时间长了点,under review基本固定在两个月左右,但总体而言比第一次更顺利些。审稿专家也很专业、客观。第一次外审后直接接收,得到专家肯定总会令人开心😃。从投稿到接收刚刚历时4个月,速度中规中矩,但是见刊速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/bd3f667e39e457213af659d09c7c2388.jpg, createdBy=e4752544775, createdName=请输入昵称, createdTime=Sat Jun 18 22:41:09 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945114, encodeId=14e49451148f, content=审稿速度:6.0 | 投稿命中率:95.0<br>经验分享:2020-10-24投稿<br>2021-02-27审回,minor revision, editor see again<br>2021-3-1修回,2天后accept<br>一篇研究IRI的基础文章,第一个审稿人未提出修改意见,第二个审稿人说不适合本杂志,第三个审稿人针对讨论提出了点小意见。对骨科研究还是很友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/943A474B8B87FD1E832DF0998921350E/100, createdBy=48852061131, createdName=shushu158, createdTime=Wed Mar 03 13:57:21 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186337, encodeId=61cf118633e51, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:脊柱创伤<br>经验分享:差评。审稿十个月,一个说观点新颖,一个说没有使用价值,我觉得这个杂志不好,审稿慢,态度不好,催稿1次,不宜接受新东西, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4061585713, createdName=duzi83410, createdTime=Thu Jan 20 09:17:50 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078121, encodeId=fb1110e812159, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:创伤骨科<br>经验分享:投稿9个月,两个意见,一个worthy of publication,一个建议大修。最后直接给拒了<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57062061668, createdName=1521ee135cm, createdTime=Wed Dec 08 16:04:47 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469975, encodeId=1dd24699e529, content=大概审稿周期:需要三个月 <br> 出版周期:目前还不清楚 <br> 是否需要审稿费和版面费:不需要 <br> 个人感觉难度:感觉难度一般,语言要求不高 <br> 是否有在线投稿系统:有 <br> 是否免费开放获取全文(open access):非 <br> 个人感觉:这个杂志虽然是骨科老牌杂志,但是个人感觉对稿件的要求较BONE和SPINE低很多,我们实验室投了两篇都已经接受发表,一个直接接受,另外一个是minor revision,所以投bone失败的战友不妨一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=浮云游子, createdTime=Tue Dec 29 08:59:00 CST 2009, time=2009-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861929, encodeId=0cb5861929ea, content=02.20投稿,2个月后小修,6天后返修回去,05.02接收,05.22 online。感觉编辑较为看中论文的创新性,临床研究的质量尚在其次。修回意见很专业,投稿流程很人性化。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Mon Jun 15 12:42:43 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578553, encodeId=939e5e855348, content=命中率高不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]
    2022-06-18 请输入昵称

    审稿速度:2.0 | 投稿命中率:25.0
    偏重的研究方向:Biomechanics;Femoral neck Fractures;骨科
    经验分享:2022-02-09投稿,2022-03under review,2022-05-23 review结束。紧张等待半个月后,2022-06-09直接接收。虽然送审时间长了点,under review基本固定在两个月左右,但总体而言比第一次更顺利些。审稿专家也很专业、客观。第一次外审后直接接收,得到专家肯定总会令人开心😃。从投稿到接收刚刚历时4个月,速度中规中矩,但是见刊速度很快。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=574122, encodeId=d3175e41224d, content=现在呢<span class="quote">zhouxindie 2019-04-12 00:00:00 发表:<br>with editor快3个月了,催了两次,说还没送审</span>, beContent=zhouxindie 2019-04-12 00:00:00 发表: with editor快3个月了,催了两次,说还没送审, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sun Jul 28 00:00:00 CST 2019, time=2019-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090422, encodeId=c37b209042230, content=我觉得这个杂志还是比较友好的,审稿不是很慢,大概一个月左右。大修一个月的时间,修回后大概1月后催了一次就直接接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=372f4741510, createdName=liangfang1024, createdTime=Mon Sep 26 10:18:02 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235190, encodeId=31b61235190c7, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:创伤<br>经验分享:本人投稿接近投了9个月,最后终于接收了,感觉这杂志的编辑还是很友好的,催了好多次,每次回复都很耐心且态度较好,不过审稿过程较慢,投这个杂志的一定要耐心,如果着急的话不建议投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erd3qzSYf75jcv9Odg4KVtGhseFWgqWtUmlzIs07zwVc5Zk9uHbp49tlsY7dDGI8df08N1cUO2utQ/132, createdBy=df882569019, createdName=kkun, createdTime=Wed Jul 27 23:08:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227282, encodeId=0917122e28267, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:Biomechanics;Femoral neck Fractures;骨科<br>经验分享:2022-02-09投稿,2022-03under review,2022-05-23 review结束。紧张等待半个月后,2022-06-09直接接收。虽然送审时间长了点,under review基本固定在两个月左右,但总体而言比第一次更顺利些。审稿专家也很专业、客观。第一次外审后直接接收,得到专家肯定总会令人开心😃。从投稿到接收刚刚历时4个月,速度中规中矩,但是见刊速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/bd3f667e39e457213af659d09c7c2388.jpg, createdBy=e4752544775, createdName=请输入昵称, createdTime=Sat Jun 18 22:41:09 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945114, encodeId=14e49451148f, content=审稿速度:6.0 | 投稿命中率:95.0<br>经验分享:2020-10-24投稿<br>2021-02-27审回,minor revision, editor see again<br>2021-3-1修回,2天后accept<br>一篇研究IRI的基础文章,第一个审稿人未提出修改意见,第二个审稿人说不适合本杂志,第三个审稿人针对讨论提出了点小意见。对骨科研究还是很友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/943A474B8B87FD1E832DF0998921350E/100, createdBy=48852061131, createdName=shushu158, createdTime=Wed Mar 03 13:57:21 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186337, encodeId=61cf118633e51, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:脊柱创伤<br>经验分享:差评。审稿十个月,一个说观点新颖,一个说没有使用价值,我觉得这个杂志不好,审稿慢,态度不好,催稿1次,不宜接受新东西, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4061585713, createdName=duzi83410, createdTime=Thu Jan 20 09:17:50 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078121, encodeId=fb1110e812159, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:创伤骨科<br>经验分享:投稿9个月,两个意见,一个worthy of publication,一个建议大修。最后直接给拒了<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57062061668, createdName=1521ee135cm, createdTime=Wed Dec 08 16:04:47 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469975, encodeId=1dd24699e529, content=大概审稿周期:需要三个月 <br> 出版周期:目前还不清楚 <br> 是否需要审稿费和版面费:不需要 <br> 个人感觉难度:感觉难度一般,语言要求不高 <br> 是否有在线投稿系统:有 <br> 是否免费开放获取全文(open access):非 <br> 个人感觉:这个杂志虽然是骨科老牌杂志,但是个人感觉对稿件的要求较BONE和SPINE低很多,我们实验室投了两篇都已经接受发表,一个直接接受,另外一个是minor revision,所以投bone失败的战友不妨一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=浮云游子, createdTime=Tue Dec 29 08:59:00 CST 2009, time=2009-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861929, encodeId=0cb5861929ea, content=02.20投稿,2个月后小修,6天后返修回去,05.02接收,05.22 online。感觉编辑较为看中论文的创新性,临床研究的质量尚在其次。修回意见很专业,投稿流程很人性化。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Mon Jun 15 12:42:43 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578553, encodeId=939e5e855348, content=命中率高不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]
    2021-03-03 shushu158

    审稿速度:6.0 | 投稿命中率:95.0
    经验分享:2020-10-24投稿
    2021-02-27审回,minor revision, editor see again
    2021-3-1修回,2天后accept
    一篇研究IRI的基础文章,第一个审稿人未提出修改意见,第二个审稿人说不适合本杂志,第三个审稿人针对讨论提出了点小意见。对骨科研究还是很友好。

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=574122, encodeId=d3175e41224d, content=现在呢<span class="quote">zhouxindie 2019-04-12 00:00:00 发表:<br>with editor快3个月了,催了两次,说还没送审</span>, beContent=zhouxindie 2019-04-12 00:00:00 发表: with editor快3个月了,催了两次,说还没送审, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sun Jul 28 00:00:00 CST 2019, time=2019-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090422, encodeId=c37b209042230, content=我觉得这个杂志还是比较友好的,审稿不是很慢,大概一个月左右。大修一个月的时间,修回后大概1月后催了一次就直接接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=372f4741510, createdName=liangfang1024, createdTime=Mon Sep 26 10:18:02 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235190, encodeId=31b61235190c7, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:创伤<br>经验分享:本人投稿接近投了9个月,最后终于接收了,感觉这杂志的编辑还是很友好的,催了好多次,每次回复都很耐心且态度较好,不过审稿过程较慢,投这个杂志的一定要耐心,如果着急的话不建议投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erd3qzSYf75jcv9Odg4KVtGhseFWgqWtUmlzIs07zwVc5Zk9uHbp49tlsY7dDGI8df08N1cUO2utQ/132, createdBy=df882569019, createdName=kkun, createdTime=Wed Jul 27 23:08:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227282, encodeId=0917122e28267, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:Biomechanics;Femoral neck Fractures;骨科<br>经验分享:2022-02-09投稿,2022-03under review,2022-05-23 review结束。紧张等待半个月后,2022-06-09直接接收。虽然送审时间长了点,under review基本固定在两个月左右,但总体而言比第一次更顺利些。审稿专家也很专业、客观。第一次外审后直接接收,得到专家肯定总会令人开心😃。从投稿到接收刚刚历时4个月,速度中规中矩,但是见刊速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/bd3f667e39e457213af659d09c7c2388.jpg, createdBy=e4752544775, createdName=请输入昵称, createdTime=Sat Jun 18 22:41:09 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945114, encodeId=14e49451148f, content=审稿速度:6.0 | 投稿命中率:95.0<br>经验分享:2020-10-24投稿<br>2021-02-27审回,minor revision, editor see again<br>2021-3-1修回,2天后accept<br>一篇研究IRI的基础文章,第一个审稿人未提出修改意见,第二个审稿人说不适合本杂志,第三个审稿人针对讨论提出了点小意见。对骨科研究还是很友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/943A474B8B87FD1E832DF0998921350E/100, createdBy=48852061131, createdName=shushu158, createdTime=Wed Mar 03 13:57:21 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186337, encodeId=61cf118633e51, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:脊柱创伤<br>经验分享:差评。审稿十个月,一个说观点新颖,一个说没有使用价值,我觉得这个杂志不好,审稿慢,态度不好,催稿1次,不宜接受新东西, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4061585713, createdName=duzi83410, createdTime=Thu Jan 20 09:17:50 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078121, encodeId=fb1110e812159, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:创伤骨科<br>经验分享:投稿9个月,两个意见,一个worthy of publication,一个建议大修。最后直接给拒了<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57062061668, createdName=1521ee135cm, createdTime=Wed Dec 08 16:04:47 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469975, encodeId=1dd24699e529, content=大概审稿周期:需要三个月 <br> 出版周期:目前还不清楚 <br> 是否需要审稿费和版面费:不需要 <br> 个人感觉难度:感觉难度一般,语言要求不高 <br> 是否有在线投稿系统:有 <br> 是否免费开放获取全文(open access):非 <br> 个人感觉:这个杂志虽然是骨科老牌杂志,但是个人感觉对稿件的要求较BONE和SPINE低很多,我们实验室投了两篇都已经接受发表,一个直接接受,另外一个是minor revision,所以投bone失败的战友不妨一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=浮云游子, createdTime=Tue Dec 29 08:59:00 CST 2009, time=2009-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861929, encodeId=0cb5861929ea, content=02.20投稿,2个月后小修,6天后返修回去,05.02接收,05.22 online。感觉编辑较为看中论文的创新性,临床研究的质量尚在其次。修回意见很专业,投稿流程很人性化。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Mon Jun 15 12:42:43 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578553, encodeId=939e5e855348, content=命中率高不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]
    2022-01-20 duzi83410

    审稿速度:12.0 | 投稿命中率:25.0
    偏重的研究方向:脊柱创伤
    经验分享:差评。审稿十个月,一个说观点新颖,一个说没有使用价值,我觉得这个杂志不好,审稿慢,态度不好,催稿1次,不宜接受新东西

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=574122, encodeId=d3175e41224d, content=现在呢<span class="quote">zhouxindie 2019-04-12 00:00:00 发表:<br>with editor快3个月了,催了两次,说还没送审</span>, beContent=zhouxindie 2019-04-12 00:00:00 发表: with editor快3个月了,催了两次,说还没送审, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sun Jul 28 00:00:00 CST 2019, time=2019-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090422, encodeId=c37b209042230, content=我觉得这个杂志还是比较友好的,审稿不是很慢,大概一个月左右。大修一个月的时间,修回后大概1月后催了一次就直接接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=372f4741510, createdName=liangfang1024, createdTime=Mon Sep 26 10:18:02 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235190, encodeId=31b61235190c7, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:创伤<br>经验分享:本人投稿接近投了9个月,最后终于接收了,感觉这杂志的编辑还是很友好的,催了好多次,每次回复都很耐心且态度较好,不过审稿过程较慢,投这个杂志的一定要耐心,如果着急的话不建议投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erd3qzSYf75jcv9Odg4KVtGhseFWgqWtUmlzIs07zwVc5Zk9uHbp49tlsY7dDGI8df08N1cUO2utQ/132, createdBy=df882569019, createdName=kkun, createdTime=Wed Jul 27 23:08:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227282, encodeId=0917122e28267, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:Biomechanics;Femoral neck Fractures;骨科<br>经验分享:2022-02-09投稿,2022-03under review,2022-05-23 review结束。紧张等待半个月后,2022-06-09直接接收。虽然送审时间长了点,under review基本固定在两个月左右,但总体而言比第一次更顺利些。审稿专家也很专业、客观。第一次外审后直接接收,得到专家肯定总会令人开心😃。从投稿到接收刚刚历时4个月,速度中规中矩,但是见刊速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/bd3f667e39e457213af659d09c7c2388.jpg, createdBy=e4752544775, createdName=请输入昵称, createdTime=Sat Jun 18 22:41:09 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945114, encodeId=14e49451148f, content=审稿速度:6.0 | 投稿命中率:95.0<br>经验分享:2020-10-24投稿<br>2021-02-27审回,minor revision, editor see again<br>2021-3-1修回,2天后accept<br>一篇研究IRI的基础文章,第一个审稿人未提出修改意见,第二个审稿人说不适合本杂志,第三个审稿人针对讨论提出了点小意见。对骨科研究还是很友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/943A474B8B87FD1E832DF0998921350E/100, createdBy=48852061131, createdName=shushu158, createdTime=Wed Mar 03 13:57:21 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186337, encodeId=61cf118633e51, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:脊柱创伤<br>经验分享:差评。审稿十个月,一个说观点新颖,一个说没有使用价值,我觉得这个杂志不好,审稿慢,态度不好,催稿1次,不宜接受新东西, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4061585713, createdName=duzi83410, createdTime=Thu Jan 20 09:17:50 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078121, encodeId=fb1110e812159, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:创伤骨科<br>经验分享:投稿9个月,两个意见,一个worthy of publication,一个建议大修。最后直接给拒了<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57062061668, createdName=1521ee135cm, createdTime=Wed Dec 08 16:04:47 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469975, encodeId=1dd24699e529, content=大概审稿周期:需要三个月 <br> 出版周期:目前还不清楚 <br> 是否需要审稿费和版面费:不需要 <br> 个人感觉难度:感觉难度一般,语言要求不高 <br> 是否有在线投稿系统:有 <br> 是否免费开放获取全文(open access):非 <br> 个人感觉:这个杂志虽然是骨科老牌杂志,但是个人感觉对稿件的要求较BONE和SPINE低很多,我们实验室投了两篇都已经接受发表,一个直接接受,另外一个是minor revision,所以投bone失败的战友不妨一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=浮云游子, createdTime=Tue Dec 29 08:59:00 CST 2009, time=2009-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861929, encodeId=0cb5861929ea, content=02.20投稿,2个月后小修,6天后返修回去,05.02接收,05.22 online。感觉编辑较为看中论文的创新性,临床研究的质量尚在其次。修回意见很专业,投稿流程很人性化。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Mon Jun 15 12:42:43 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578553, encodeId=939e5e855348, content=命中率高不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]
    2021-12-08 1521ee135cm

    审稿速度:12.0 | 投稿命中率:25.0
    偏重的研究方向:创伤骨科
    经验分享:投稿9个月,两个意见,一个worthy of publication,一个建议大修。最后直接给拒了

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=574122, encodeId=d3175e41224d, content=现在呢<span class="quote">zhouxindie 2019-04-12 00:00:00 发表:<br>with editor快3个月了,催了两次,说还没送审</span>, beContent=zhouxindie 2019-04-12 00:00:00 发表: with editor快3个月了,催了两次,说还没送审, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sun Jul 28 00:00:00 CST 2019, time=2019-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090422, encodeId=c37b209042230, content=我觉得这个杂志还是比较友好的,审稿不是很慢,大概一个月左右。大修一个月的时间,修回后大概1月后催了一次就直接接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=372f4741510, createdName=liangfang1024, createdTime=Mon Sep 26 10:18:02 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235190, encodeId=31b61235190c7, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:创伤<br>经验分享:本人投稿接近投了9个月,最后终于接收了,感觉这杂志的编辑还是很友好的,催了好多次,每次回复都很耐心且态度较好,不过审稿过程较慢,投这个杂志的一定要耐心,如果着急的话不建议投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erd3qzSYf75jcv9Odg4KVtGhseFWgqWtUmlzIs07zwVc5Zk9uHbp49tlsY7dDGI8df08N1cUO2utQ/132, createdBy=df882569019, createdName=kkun, createdTime=Wed Jul 27 23:08:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227282, encodeId=0917122e28267, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:Biomechanics;Femoral neck Fractures;骨科<br>经验分享:2022-02-09投稿,2022-03under review,2022-05-23 review结束。紧张等待半个月后,2022-06-09直接接收。虽然送审时间长了点,under review基本固定在两个月左右,但总体而言比第一次更顺利些。审稿专家也很专业、客观。第一次外审后直接接收,得到专家肯定总会令人开心😃。从投稿到接收刚刚历时4个月,速度中规中矩,但是见刊速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/bd3f667e39e457213af659d09c7c2388.jpg, createdBy=e4752544775, createdName=请输入昵称, createdTime=Sat Jun 18 22:41:09 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945114, encodeId=14e49451148f, content=审稿速度:6.0 | 投稿命中率:95.0<br>经验分享:2020-10-24投稿<br>2021-02-27审回,minor revision, editor see again<br>2021-3-1修回,2天后accept<br>一篇研究IRI的基础文章,第一个审稿人未提出修改意见,第二个审稿人说不适合本杂志,第三个审稿人针对讨论提出了点小意见。对骨科研究还是很友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/943A474B8B87FD1E832DF0998921350E/100, createdBy=48852061131, createdName=shushu158, createdTime=Wed Mar 03 13:57:21 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186337, encodeId=61cf118633e51, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:脊柱创伤<br>经验分享:差评。审稿十个月,一个说观点新颖,一个说没有使用价值,我觉得这个杂志不好,审稿慢,态度不好,催稿1次,不宜接受新东西, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4061585713, createdName=duzi83410, createdTime=Thu Jan 20 09:17:50 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078121, encodeId=fb1110e812159, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:创伤骨科<br>经验分享:投稿9个月,两个意见,一个worthy of publication,一个建议大修。最后直接给拒了<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57062061668, createdName=1521ee135cm, createdTime=Wed Dec 08 16:04:47 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469975, encodeId=1dd24699e529, content=大概审稿周期:需要三个月 <br> 出版周期:目前还不清楚 <br> 是否需要审稿费和版面费:不需要 <br> 个人感觉难度:感觉难度一般,语言要求不高 <br> 是否有在线投稿系统:有 <br> 是否免费开放获取全文(open access):非 <br> 个人感觉:这个杂志虽然是骨科老牌杂志,但是个人感觉对稿件的要求较BONE和SPINE低很多,我们实验室投了两篇都已经接受发表,一个直接接受,另外一个是minor revision,所以投bone失败的战友不妨一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=浮云游子, createdTime=Tue Dec 29 08:59:00 CST 2009, time=2009-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861929, encodeId=0cb5861929ea, content=02.20投稿,2个月后小修,6天后返修回去,05.02接收,05.22 online。感觉编辑较为看中论文的创新性,临床研究的质量尚在其次。修回意见很专业,投稿流程很人性化。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Mon Jun 15 12:42:43 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578553, encodeId=939e5e855348, content=命中率高不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]
    2009-12-29 浮云游子

    大概审稿周期:需要三个月
    出版周期:目前还不清楚
    是否需要审稿费和版面费:不需要
    个人感觉难度:感觉难度一般,语言要求不高
    是否有在线投稿系统:有
    是否免费开放获取全文(open access):非
    个人感觉:这个杂志虽然是骨科老牌杂志,但是个人感觉对稿件的要求较BONE和SPINE低很多,我们实验室投了两篇都已经接受发表,一个直接接受,另外一个是minor revision,所以投bone失败的战友不妨一试。

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=574122, encodeId=d3175e41224d, content=现在呢<span class="quote">zhouxindie 2019-04-12 00:00:00 发表:<br>with editor快3个月了,催了两次,说还没送审</span>, beContent=zhouxindie 2019-04-12 00:00:00 发表: with editor快3个月了,催了两次,说还没送审, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sun Jul 28 00:00:00 CST 2019, time=2019-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090422, encodeId=c37b209042230, content=我觉得这个杂志还是比较友好的,审稿不是很慢,大概一个月左右。大修一个月的时间,修回后大概1月后催了一次就直接接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=372f4741510, createdName=liangfang1024, createdTime=Mon Sep 26 10:18:02 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235190, encodeId=31b61235190c7, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:创伤<br>经验分享:本人投稿接近投了9个月,最后终于接收了,感觉这杂志的编辑还是很友好的,催了好多次,每次回复都很耐心且态度较好,不过审稿过程较慢,投这个杂志的一定要耐心,如果着急的话不建议投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erd3qzSYf75jcv9Odg4KVtGhseFWgqWtUmlzIs07zwVc5Zk9uHbp49tlsY7dDGI8df08N1cUO2utQ/132, createdBy=df882569019, createdName=kkun, createdTime=Wed Jul 27 23:08:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227282, encodeId=0917122e28267, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:Biomechanics;Femoral neck Fractures;骨科<br>经验分享:2022-02-09投稿,2022-03under review,2022-05-23 review结束。紧张等待半个月后,2022-06-09直接接收。虽然送审时间长了点,under review基本固定在两个月左右,但总体而言比第一次更顺利些。审稿专家也很专业、客观。第一次外审后直接接收,得到专家肯定总会令人开心😃。从投稿到接收刚刚历时4个月,速度中规中矩,但是见刊速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/bd3f667e39e457213af659d09c7c2388.jpg, createdBy=e4752544775, createdName=请输入昵称, createdTime=Sat Jun 18 22:41:09 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945114, encodeId=14e49451148f, content=审稿速度:6.0 | 投稿命中率:95.0<br>经验分享:2020-10-24投稿<br>2021-02-27审回,minor revision, editor see again<br>2021-3-1修回,2天后accept<br>一篇研究IRI的基础文章,第一个审稿人未提出修改意见,第二个审稿人说不适合本杂志,第三个审稿人针对讨论提出了点小意见。对骨科研究还是很友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/943A474B8B87FD1E832DF0998921350E/100, createdBy=48852061131, createdName=shushu158, createdTime=Wed Mar 03 13:57:21 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186337, encodeId=61cf118633e51, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:脊柱创伤<br>经验分享:差评。审稿十个月,一个说观点新颖,一个说没有使用价值,我觉得这个杂志不好,审稿慢,态度不好,催稿1次,不宜接受新东西, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4061585713, createdName=duzi83410, createdTime=Thu Jan 20 09:17:50 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078121, encodeId=fb1110e812159, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:创伤骨科<br>经验分享:投稿9个月,两个意见,一个worthy of publication,一个建议大修。最后直接给拒了<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57062061668, createdName=1521ee135cm, createdTime=Wed Dec 08 16:04:47 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469975, encodeId=1dd24699e529, content=大概审稿周期:需要三个月 <br> 出版周期:目前还不清楚 <br> 是否需要审稿费和版面费:不需要 <br> 个人感觉难度:感觉难度一般,语言要求不高 <br> 是否有在线投稿系统:有 <br> 是否免费开放获取全文(open access):非 <br> 个人感觉:这个杂志虽然是骨科老牌杂志,但是个人感觉对稿件的要求较BONE和SPINE低很多,我们实验室投了两篇都已经接受发表,一个直接接受,另外一个是minor revision,所以投bone失败的战友不妨一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=浮云游子, createdTime=Tue Dec 29 08:59:00 CST 2009, time=2009-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861929, encodeId=0cb5861929ea, content=02.20投稿,2个月后小修,6天后返修回去,05.02接收,05.22 online。感觉编辑较为看中论文的创新性,临床研究的质量尚在其次。修回意见很专业,投稿流程很人性化。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Mon Jun 15 12:42:43 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578553, encodeId=939e5e855348, content=命中率高不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]
    2020-06-15 ms6267360147337765

    02.20投稿,2个月后小修,6天后返修回去,05.02接收,05.22 online。感觉编辑较为看中论文的创新性,临床研究的质量尚在其次。修回意见很专业,投稿流程很人性化。

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=574122, encodeId=d3175e41224d, content=现在呢<span class="quote">zhouxindie 2019-04-12 00:00:00 发表:<br>with editor快3个月了,催了两次,说还没送审</span>, beContent=zhouxindie 2019-04-12 00:00:00 发表: with editor快3个月了,催了两次,说还没送审, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sun Jul 28 00:00:00 CST 2019, time=2019-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090422, encodeId=c37b209042230, content=我觉得这个杂志还是比较友好的,审稿不是很慢,大概一个月左右。大修一个月的时间,修回后大概1月后催了一次就直接接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=372f4741510, createdName=liangfang1024, createdTime=Mon Sep 26 10:18:02 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235190, encodeId=31b61235190c7, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:创伤<br>经验分享:本人投稿接近投了9个月,最后终于接收了,感觉这杂志的编辑还是很友好的,催了好多次,每次回复都很耐心且态度较好,不过审稿过程较慢,投这个杂志的一定要耐心,如果着急的话不建议投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erd3qzSYf75jcv9Odg4KVtGhseFWgqWtUmlzIs07zwVc5Zk9uHbp49tlsY7dDGI8df08N1cUO2utQ/132, createdBy=df882569019, createdName=kkun, createdTime=Wed Jul 27 23:08:41 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227282, encodeId=0917122e28267, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:Biomechanics;Femoral neck Fractures;骨科<br>经验分享:2022-02-09投稿,2022-03under review,2022-05-23 review结束。紧张等待半个月后,2022-06-09直接接收。虽然送审时间长了点,under review基本固定在两个月左右,但总体而言比第一次更顺利些。审稿专家也很专业、客观。第一次外审后直接接收,得到专家肯定总会令人开心😃。从投稿到接收刚刚历时4个月,速度中规中矩,但是见刊速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/14/bd3f667e39e457213af659d09c7c2388.jpg, createdBy=e4752544775, createdName=请输入昵称, createdTime=Sat Jun 18 22:41:09 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945114, encodeId=14e49451148f, content=审稿速度:6.0 | 投稿命中率:95.0<br>经验分享:2020-10-24投稿<br>2021-02-27审回,minor revision, editor see again<br>2021-3-1修回,2天后accept<br>一篇研究IRI的基础文章,第一个审稿人未提出修改意见,第二个审稿人说不适合本杂志,第三个审稿人针对讨论提出了点小意见。对骨科研究还是很友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/943A474B8B87FD1E832DF0998921350E/100, createdBy=48852061131, createdName=shushu158, createdTime=Wed Mar 03 13:57:21 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186337, encodeId=61cf118633e51, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:脊柱创伤<br>经验分享:差评。审稿十个月,一个说观点新颖,一个说没有使用价值,我觉得这个杂志不好,审稿慢,态度不好,催稿1次,不宜接受新东西, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4061585713, createdName=duzi83410, createdTime=Thu Jan 20 09:17:50 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078121, encodeId=fb1110e812159, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:创伤骨科<br>经验分享:投稿9个月,两个意见,一个worthy of publication,一个建议大修。最后直接给拒了<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57062061668, createdName=1521ee135cm, createdTime=Wed Dec 08 16:04:47 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469975, encodeId=1dd24699e529, content=大概审稿周期:需要三个月 <br> 出版周期:目前还不清楚 <br> 是否需要审稿费和版面费:不需要 <br> 个人感觉难度:感觉难度一般,语言要求不高 <br> 是否有在线投稿系统:有 <br> 是否免费开放获取全文(open access):非 <br> 个人感觉:这个杂志虽然是骨科老牌杂志,但是个人感觉对稿件的要求较BONE和SPINE低很多,我们实验室投了两篇都已经接受发表,一个直接接受,另外一个是minor revision,所以投bone失败的战友不妨一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=浮云游子, createdTime=Tue Dec 29 08:59:00 CST 2009, time=2009-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861929, encodeId=0cb5861929ea, content=02.20投稿,2个月后小修,6天后返修回去,05.02接收,05.22 online。感觉编辑较为看中论文的创新性,临床研究的质量尚在其次。修回意见很专业,投稿流程很人性化。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Mon Jun 15 12:42:43 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578553, encodeId=939e5e855348, content=命中率高不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]
    2019-10-25 147612bem32暂无昵称

    命中率高不

    0

共48条页码: 1/5页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分